-
Allergan's Strength Lies In Its New Products And Robust Pipeline
Monday, December 5, 2016 - 1:04pm | 251Read More...Since the market’s response to Allergan plc Ordinary Shares (NYSE: AGN)’s disappointing earnings and reduced guidance on November 2, shares are trading just above the company's 52-week low of $184.50. Rating's Thesis Argus maintains its Buy rating for the stock while drastically lowing...


